🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence

RecruitingNAAges 18 Years - anyAllMedical University Innsbruck
NCT06714344 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Heart failure patients within the HM programme

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: AMPEL, CIP, Version: 1.2 Date: 27.03.2024 1. Written, signed and dated informed consent for inclusion in the HM programme 2. Male and female patients over 18 years of age. 3. Hospitalised for decompensated heart failure requiring intravenous diuretics 4. Need for iv diuresis in nonhospital setting because of impending hospitalization for cardiac decompensation Exclusion Criteria: 1. Multimorbidity (Charlson Comorbidity Index \> 6) 2. Dementia 3. Lack of willingness to participate
💊

What it tests

  • KITGuideMe: W61-MD41-AIT, version 1.0.0
📍

Where

2 sites
Medical University of Graz, University Hospital for Internal Medicine (Cardiology)
Graz, Austria
Medical University of Innsbruck, University Hospital for Internal Medicine III (Cardiology and Angiology)
Innsbruck, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy